More activation of DABK/BKB1R axis signaling during COVID-19 contributes to exaggerated inflammation, vasodilation, leukocyte extravasation, angioedema, nitric oxide production, arachidonic acid release, and acute respiratory distress syndrome (ARDS) development (71, 75). Here, BDKRB1 is linked to acute respiratory distress syndrome.